Close Menu
The Startup StoryThe Startup Story
  • Business
  • Lifestyle
  • National
  • Education
  • Health
  • Technology
  • World

Subscribe to Updates

Get the latest creative news from FooBar about art, design and business.

What's Hot

Invisalign by Dr. Swetha Reddy in Hyderabad Champions a “Diagnosis First” Approach as Gen Z Embraces Invisible Teeth Straightening

November 20, 2026

Three Shorty Awards. One Big Fight. Girl Effect’s India vs Tech Hinsa campaign brings Global Spotlight on online violence

November 20, 2026

Invisalign Relapse Correction by Hyderabad’s Trusted Orthodontist Dr. Kishor Gunnam Marks a Remarkable Smile Transformation

November 20, 2026
Facebook X (Twitter) Instagram
Trending
  • Invisalign by Dr. Swetha Reddy in Hyderabad Champions a “Diagnosis First” Approach as Gen Z Embraces Invisible Teeth Straightening
  • Three Shorty Awards. One Big Fight. Girl Effect’s India vs Tech Hinsa campaign brings Global Spotlight on online violence
  • Invisalign Relapse Correction by Hyderabad’s Trusted Orthodontist Dr. Kishor Gunnam Marks a Remarkable Smile Transformation
  • Building ISAK Fragrances: From a 170 Year Family Legacy to a Modern Luxury Brand
  • From the Mountains to the Sea: Captain Sanjay’s Initiative Opens New Career Opportunities for Himachal’s Daughters in the Merchant Navy
  • Shanti Educational Initiatives Wins BSE Clearance for Merger With Solar Powerhouse GREW Energy
  • How IH Global Helps Businesses Build Powerful Brand Experiences Through Exhibition Design, Trade Shows and Experiential Technology
  • How to Choose Furniture That Complements Your Lifestyle and Living Space
The Startup StoryThe Startup Story
  • Business
  • Lifestyle
  • National
  • Education
  • Health
  • Technology
  • World
The Startup StoryThe Startup Story
Home»Technology»Genient Advances Precision Diagnostics for India with Clinical Genomics and AMR-Focused NGS Solutions
Technology

Genient Advances Precision Diagnostics for India with Clinical Genomics and AMR-Focused NGS Solutions

Arjun SinghBy Arjun SinghFebruary 10, 2026No Comments
Facebook Twitter Pinterest LinkedIn WhatsApp Reddit Tumblr Email
Share
Facebook Twitter LinkedIn Pinterest Email

Noida (Uttar Pradesh) [India], February 10: Genient, a Noida-based genomics and molecular diagnostics company founded in 2017, is strengthening India’s precision healthcare ecosystem by delivering platform-agnostic, India-relevant molecular and next-generation sequencing (NGS) solutions tailored to the country’s real disease burden, including infectious diseases, antimicrobial resistance (AMR), oncology, and epigenetics.

With India facing a high prevalence of tuberculosis, viral hepatitis, HIV, sepsis, and rising antimicrobial resistance, Genient’s clinical genomics portfolio is designed to support accurate diagnosis, drug-resistance profiling, and surveillance needs across hospitals, reference laboratories, and research institutions.

The company offers comprehensive NGS-based drug resistance testing for infectious diseases such as HIV, HBV, HCV, Influenza, and CMV, along with advanced solutions for Mycobacterium tuberculosis (MTB), fungal identification, and metagenomics. Its syndrome-based multiplex panels include one of the widest ranges of respiratory panels in the Indian market, addressing common and emerging pathogens. Genient also provides Sepsis and AMR-focused assays to support timely and targeted therapeutic decisions in critical care settings.

In oncology and molecular pathology, the company is expanding access to clinically relevant assays, including solutions for chronic myeloid leukemia (CML) and epigenetics-based methylation testing, supporting both diagnostic and research applications. Complementing these offerings are comprehensive nucleic acid preparation kits for DNA, RNA, and total nucleic acids, enabling end-to-end molecular workflows.

At the core of Genient’s offering is the integration of ABL Diagnostics’ infectious disease NGS assays with the DeepChek® bioinformatics platform, delivering standardized, decision-grade interpretation for pathogen identification, clinical genotyping, and drug resistance profiling. Optimized for sequencing platforms widely used in India, including Illumina, Oxford Nanopore Technologies (ONT), and Thermo Fisher, these workflows enable laboratories to expand NGS capabilities without significant infrastructure changes. Streamlined library preparation and in-country, audit-ready data analysis are designed to reduce interpretation variability, accelerate turnaround times, and support antimicrobial stewardship, outbreak response, and national surveillance programs.

A key differentiator for Genient is its emphasis on in-country, auditable bioinformatics pipelines, allowing clinical laboratories and research institutions to perform data analysis within India while meeting regulatory and data governance expectations. This capability is particularly relevant for national surveillance programs, epidemiological studies, and academic research, where transparency and traceability of data processing are critical.

Director Mr. Anil Kumar, who brings prior experience from global technology and consulting firms including HCL Technologies and EY, said the company’s mission is to bridge advanced genomics with real-world clinical needs in India. “Our focus has always been to make sophisticated molecular diagnostics accessible, reliable, and aligned with the disease patterns seen in Indian patients, while also supporting public health surveillance and research,” he said.

Genient’s leadership was further strengthened in 2026 with the appointment of Brijesh Singh as Chief Executive Officer. With extensive experience across global diagnostics organizations including Roche, Bio-Rad, Dr. Lal PathLabs, and Fast Track Diagnostics (FTD), later acquired by Siemens Healthineers, Singh brings deep expertise in IVD commercialization and manufacturing ecosystems. He said Genient aims to collaborate with global and Indian partners to expand advanced molecular testing capabilities and support localized manufacturing initiatives in the future.

As India continues to invest in genomics-led healthcare and disease surveillance, Genient positions itself as a technology partner for clinicians, researchers, and policymakers seeking scalable, clinically relevant, and locally adaptable molecular diagnostics solutions.

If you object to the content of this press release, please notify us at pr.error.rectification@gmail.com. We will respond and rectify the situation within 24 hours

technology
Share. Facebook Twitter Pinterest LinkedIn Tumblr Telegram Email
Arjun Singh
  • Website

Related Posts

Infinite Electronics Builds Strategic Global Capability in Pune to Power Its Next Phase of Growth

November 18, 2026

NeWOT to Showcase Its AI Capabilities and Product Portfolio at Bengaluru Tech Summit 2026

November 18, 2026

IIM Calcutta launches inaugural AI-Powered Product Management programme

November 18, 2026

Comments are closed.

Top Posts

Invisalign by Dr. Swetha Reddy in Hyderabad Champions a “Diagnosis First” Approach as Gen Z Embraces Invisible Teeth Straightening

November 20, 2026

Can we guess, how much she is happy?

February 22, 2020

When sunrise and the day begins.

February 22, 2020

Make your own inhouse library and learn

February 22, 2020
Don't Miss
Lifestyle

Invisalign by Dr. Swetha Reddy in Hyderabad Champions a “Diagnosis First” Approach as Gen Z Embraces Invisible Teeth Straightening

By Arjun SinghNovember 20, 2026

New Delhi [India], November 20: Braces are no longer just for teenagers. Across Hyderabad, students,…

Three Shorty Awards. One Big Fight. Girl Effect’s India vs Tech Hinsa campaign brings Global Spotlight on online violence

November 20, 2026

Invisalign Relapse Correction by Hyderabad’s Trusted Orthodontist Dr. Kishor Gunnam Marks a Remarkable Smile Transformation

November 20, 2026

Building ISAK Fragrances: From a 170 Year Family Legacy to a Modern Luxury Brand

November 20, 2026
Most Popular

Invisalign by Dr. Swetha Reddy in Hyderabad Champions a “Diagnosis First” Approach as Gen Z Embraces Invisible Teeth Straightening

November 20, 2026

Can we guess, how much she is happy?

February 22, 2020

When sunrise and the day begins.

February 22, 2020
Categories
  • Business
  • Business News
  • Education
  • Entertainment
  • Finance
  • Health
  • Lifestyle
  • National
  • Press Release
  • Sports
  • Technology
  • Uncategorized
  • World
Our Picks

Invisalign by Dr. Swetha Reddy in Hyderabad Champions a “Diagnosis First” Approach as Gen Z Embraces Invisible Teeth Straightening

November 20, 2026

Three Shorty Awards. One Big Fight. Girl Effect’s India vs Tech Hinsa campaign brings Global Spotlight on online violence

November 20, 2026

Invisalign Relapse Correction by Hyderabad’s Trusted Orthodontist Dr. Kishor Gunnam Marks a Remarkable Smile Transformation

November 20, 2026

Type above and press Enter to search. Press Esc to cancel.